Haematology

Dr Renee Eslick
Podcasts iconPodcasts

Practical tips on oral supplementation, how to address common issues such as intolerance and lack of compliance.

Dr Patrick Coleman
Clinical Articles iconClinical Articles

Iron deficiency, its identification and optimal management is more complex than many doctors realise.

Dr Patrick Coleman
Clinical Articles iconClinical Articles

There are many exceptions to the interpretation of iron studies and patient co-morbidities become an important consideration.

Prof John Olynyk
Podcasts iconPodcasts

Whom should you suspect and whom should we screen for this common condition?

Prof Lawrence McMahon
Podcasts iconPodcasts

In this Healthed lecture, Prof Lawrence McMahon covers iron metabolism, IV infusions, and hypophosphataemia.

Dr Patrick Coleman
Podcasts iconPodcasts

In this Healthed lecture, Dr Patrick Coleman will guide clinicians through the various components reported on in iron studies and the implications when results are outside the normal range.

Prof Andrew Sindone
Videos iconVideos

In this Product Explainer, Prof Andrew Sindone, cardiologist at Concord and Ryde Hospitals in Sydney, explains the role of rivaroxaban in anticoagulation and when and to whom it can be prescribed (5 mins).

Clinical A/Prof Pradeep Jayasuriya
Podcasts iconPodcasts
Dr Patrick Coleman
Podcasts iconPodcasts

Oral iron absorption in patients with chronic inflammatory conditions is very poor

A/Prof David Colquhoun
Podcasts iconPodcasts

A/Prof Colquhoun explains that iron deficiency is common in people with chronic disease and covers practical considerations of chronic diseases that are most at risk of affecting iron stores and how iron deficiency associated with chronic disease is best managed in the primary care setting. 

Dr Renee Eslick
Podcasts iconPodcasts

How the significance of iron deficiency is often not appreciated by patients which is why a dietary approach is frequently unsuccessful.

A/Prof David Sullivan
Podcasts iconPodcasts

How to manage a patient assessed to be at Intermediate Absolute CV risk